Nat Commun. 2023 Nov 15. 14(1): 7372
Ann-Christin Gnirck,
Marie-Sophie Philipp,
Alex Waterhölter,
Malte Wunderlich,
Nikhat Shaikh,
Virginia Adamiak,
Lena Henneken,
Tobias Kautz,
Tingting Xiong,
Daniela Klaus,
Pascal Tomczyk,
Mohamad M Al-Bahra,
Dirk Menche,
Mark Walkenhorst,
Olivier Lantz,
Anne Willing,
Manuel A Friese,
Tobias B Huber,
Christian F Krebs,
Ulf Panzer,
Christian Kurts,
Jan-Eric Turner.
Mucosal-associated invariant T (MAIT) cells have been implicated in various inflammatory diseases of barrier organs, but so far, their role in kidney disease is unclear. Here we report that MAIT cells that recognize their prototypical ligand, the vitamin B2 intermediate 5-OP-RU presented by MR1, reside in human and mouse kidneys. Single cell RNAseq analysis reveals several intrarenal MAIT subsets, and one, carrying the genetic fingerprint of tissue-resident MAIT17 cells, is activated and expanded in a murine model of crescentic glomerulonephritis (cGN). An equivalent subset is also present in kidney biopsies of patients with anti-neutrophil cytoplasmatic antibody (ANCA)-associated cGN. MAIT cell-deficient MR1 mice show aggravated disease, whereas B6-MAITCAST mice, harboring higher MAIT cell numbers, are protected from cGN. The expanded MAIT17 cells express anti-inflammatory mediators known to suppress cGN, such as CTLA-4, PD-1, and TGF-β. Interactome analysis predicts CXCR6 - CXCL16-mediated cross-talk with renal mononuclear phagocytes, known to drive cGN progression. In line, we find that cGN is aggravated upon CXCL16 blockade. Finally, we present an optimized 5-OP-RU synthesis method which we apply to attenuating cGN in mice. In summary, we propose that CXCR6+ MAIT cells might play a protective role in cGN, implicating them as a potential target for anti-inflammatory therapies.